Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

November 30, 2006

Conditions
Phenylketonurias
Interventions
DRUG

Sapropterin Dihydrochloride

Phenoptin, provided in tablets containing 100 mg of sapropterin dihydrochloride each, was administered orally once daily in the morning as the number of tablets equivalent to a 20mg/kg/day dose dissolved in 4-8 oz (120-240 mL) of water or apple juice for 6 weeks. A follow-up call or visit was made 4 weeks later during this double-blind, placebo-controlled study.

DRUG

Placebo

Placebo, provided as tablets similar to Phenoptin tablets, was administered orally once daily in the morning as the number of tablets equivalent to a 20mg/kg/day dose dissolved in 4 8 oz (120-240 mL) of water or apple juice. for 6 weeks. A follow-up call or visit was made 4 weeks later during this double-blind, placebo-controlled study.

Trial Locations (9)

Unknown

Los Angeles

Oakland

Sacramento

San Jose

Chicago

Boston

Minneapolis

St Louis

Salt Lake City

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY